Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2015, Article ID 189232, 11 pages
http://dx.doi.org/10.1155/2015/189232
Review Article

Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis

1Infectious and Tropical Diseases Unit, Public Health and Diagnostic Institute, College of Medical Sciences, Northwest University, PMB 3220, Kano, Nigeria
2Infectious and Tropical Diseases Unit, Department of Medicine, Aminu Kano Teaching Hospital, Bayero University, PMB 3452, Kano, Nigeria
3Department of Community Medicine, Aminu Kano Teaching Hospital, Bayero University, PMB 3452, Kano, Nigeria
4Department of Pharmacy, Aminu Kano Teaching Hospital, PMB 3452, Kano, Nigeria
5Department of Medicine, Aminu Kano Teaching Hospital, Bayero University, PMB 3452, Kano, Nigeria
6Infectious and Tropical Diseases Unit, Department of Paediatrics, Aminu Kano Teaching Hospital, Bayero University, PMB 3452, Kano, Nigeria

Received 16 December 2014; Revised 3 May 2015; Accepted 4 May 2015

Academic Editor: Aditya Prasad Dash

Copyright © 2015 Ahmad M. Yakasai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. K. Mutabingwa, “Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!,” Acta Tropica, vol. 95, no. 3, pp. 305–315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. Tanzanian National Bureau of Statistics, Household Budget Survey, 2001, http://www.nbs.go.tz/tnada/index.php/ddibrowser/1.
  3. World Health Organization, “Antimalarial drug combination therapy. Report of a WHO technical consultation,” WHO/CDS/RBM 2001.35, World Health Organization, Geneva, Switzerland, 2001. View at Google Scholar
  4. International Artemisinin Study Group, “Artesunate combinations for treatment of malaria: meta-analysis,” The Lancet, vol. 363, no. 9402, pp. 9–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Y. Whegang, R. Tahar, V. N. Foumane et al., “Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon,” Malaria Journal, vol. 9, no. 1, article 56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. World Health Organization, Antimalarial Drug Combination Therapy: Report of a Technical Consultation, WHO, Geneva, Switzerland, 2001.
  7. A. Bosman and K. N. Mendis, “A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies,” American Journal of Tropical Medicine and Hygiene, vol. 77, supplement 6, pp. 193–197, 2007. View at Google Scholar · View at Scopus
  8. G. O. Adjei, A. K. Darkwah, B. Q. Goka et al., “Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in Ghana,” Ghana Medical Journal, vol. 42, no. 3, pp. 99–106, 2008. View at Google Scholar
  9. K. Yeboah-Antwi, J. O. Gyapong, I. K. Asare, G. Barnish, D. B. Evans, and S. Adjei, “Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment,” Bulletin of the World Health Organization, vol. 79, no. 5, pp. 394–399, 2001. View at Google Scholar · View at Scopus
  10. K. Banek, M. Lalani, S. G. Staedke, and D. Chandramohan, “Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence,” Malaria Journal, vol. 13, no. 1, article 7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Bruxvoort, C. Goodman, S. P. Kachur, and D. Schellenberg, “How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs,” PLoS ONE, vol. 9, no. 1, Article ID e84555, 15 pages, 2014. View at Publisher · View at Google Scholar
  12. E. O. Onyango, G. Ayodo, C. A. Watsierah et al., “Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya,” BMC Infectious Diseases, vol. 12, article 143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. H. Downs and N. Black, “The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions,” Journal of Epidemiology and Community Health, vol. 52, no. 6, pp. 377–384, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 7, Article ID e1000097, 2009. View at Publisher · View at Google Scholar
  15. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group,” The Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. R. DerSimonian and N. Laird, “Meta-analysis in clinical trials,” Controlled Clinical Trials, vol. 7, no. 3, pp. 177–188, 1986. View at Publisher · View at Google Scholar · View at Scopus
  17. C. B. Begg and M. Mazumdar, “Operating characteristics of a rank correlation test for publication bias,” Biometrics, vol. 50, no. 4, pp. 1088–1101, 1994. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  18. M. Egger, G. D. Smith, M. Schneider, and C. Minder, “Bias in meta-analysis detected by a simple, graphical test,” British Medical Journal, vol. 315, no. 7109, pp. 629–634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” The British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Lau, J. P. A. Ioannidis, N. Terrin, C. H. Schmid, and I. Olkin, “The case of the misleading funnel plot,” British Medical Journal, vol. 333, no. 7568, pp. 597–600, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tobias, “Assessing the influence of a single study in the meta-anyalysis estimate,” Stata Technical Bulletin, vol. 8, no. 47, pp. 15–17, 1999. View at Google Scholar
  22. I. O. Ajayi, E. N. Browne, B. Garshong et al., “Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites,” Malaria Journal, vol. 7, article 6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. K. P. Asante, R. Owusu, D. Dosoo et al., “Adherence to artesunate-amodiaquine therapy for uncomplicated malaria in rural ghana: a randomised trial of supervised versus unsupervised drug administration,” Journal of Tropical Medicine, vol. 2009, Article ID 529583, 7 pages, 2009. View at Publisher · View at Google Scholar
  24. H. Lawford, D. Zurovac, L. O'Reilly et al., “Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya,” Malaria Journal, vol. 10, article 281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Kabanywanyi, C. Lengeler, P. Kasim et al., “Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania,” Malaria Journal, vol. 9, no. 1, article 48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Gerstl, S. Dunkley, A. Mukhtar, S. Baker, and J. Maikere, “Successful introduction of artesunate combination therapy is not enough to fight malaria: results from an adherence study in Sierra Leone,” Transactions of the Royal Society of Tropical Medicine & Hygiene, vol. 104, no. 5, pp. 328–335, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Beer, A. S. Ali, G. Rotllant et al., “Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania,” Tropical Medicine and International Health, vol. 14, no. 7, pp. 766–774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Bell, D. Wootton, M. Mukaka et al., “Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi,” Malaria Journal, vol. 8, no. 1, article 204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Lemma, C. Löfgren, and M. S. Sebastian, “Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia,” Malaria Journal, vol. 10, article 349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. K. E. Mace, D. Mwandama, J. Jafali et al., “Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in Rural Malawi,” Clinical Infectious Diseases, vol. 53, no. 8, pp. 772–779, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Fogg, F. Bajunirwe, P. Piola et al., “Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 5, pp. 525–530, 2004. View at Google Scholar · View at Scopus
  32. S. P. Kachur, R. A. Khatib, E. Kaizer, S. S. Fox, S. M. Abdulla, and P. B. Bloland, “Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 6, pp. 715–722, 2004. View at Google Scholar · View at Scopus
  33. E. Depoortere, J.-P. Guthmann, N. Sipilanyambe et al., “Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia,” Tropical Medicine and International Health, vol. 9, no. 1, pp. 62–67, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Chinbuah, J. O. Gyapong, F. Pagnoni, E. K. Wellington, and M. Gyapong, “Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6–59 months old in Ghana,” Tropical Medicine and International Health, vol. 11, no. 7, pp. 1003–1016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. O. Simba, D. Kakoko, G. Tomson et al., “Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 106, no. 1, pp. 3–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. Cohen, E. Yavuz, A. Morris, J. Arkedis, and O. Sabot, “Do patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Uganda,” Malaria Journal, vol. 11, article 83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Achan, J. K. Tibenderana, D. Kyabayinze et al., “Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial,” British Medical Journal, vol. 339, Article ID b2763, pp. 1–8, 2009. View at Google Scholar
  38. A. O. Amponsah, H. Vosper, and A. F. A. Marfo, “Patient related factors affecting adherence to antimalarial medication in an urban estate in Ghana,” Malaria Research and Treatment, vol. 2015, Article ID 452539, 8 pages, 2015. View at Publisher · View at Google Scholar
  39. W. Aung, A. M. Dondorp, M. Min et al., “Assessment of adherence to three day course of artemeter-lumefantrine treatment in Rhakine state, Myanmar,” JITMM Proceedings 3, vol. 4, pp. 16–23, 2015. View at Google Scholar
  40. K. Bruxvoort, A. Kalolella, M. Cairns et al., “Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?” Malaria Journal, vol. 14, no. 1, pp. 1–12, 2015. View at Publisher · View at Google Scholar
  41. K. Congpuong, P. Bualombai, V. Banmairuroi, and K. Na-Bangchang, “Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria,” Malaria Journal, vol. 9, article 43, pp. 2–8, 2010. View at Publisher · View at Google Scholar
  42. V. L. Ewing, D. J. Terlouw, A. Kapinda et al., “Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa district of Malawi: a mixed methods study,” Malaria Journal, vol. 14, article 13, pp. 2–10, 2015. View at Publisher · View at Google Scholar
  43. G. R. Gore-Langton, N. Alenwi, J. Mungai et al., “Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting,” Malaria Journal, vol. 14, no. 1, article 125, 10 pages, 2015. View at Publisher · View at Google Scholar
  44. M. R. Siddiqui, A. Willis, K. Bil, J. Singh, E. Mukomena Sompwe, and C. Ariti, “Adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Democratic Republic of the Congo,” F1000Research, vol. 4, no. 51, pp. 1–16, 2015. View at Publisher · View at Google Scholar
  45. J. O. Ogolla, S. O. Ayaya, and C. A. Otieno, “Levels of adherence to coartem in the routine treatment of uncomplicated malaria in children aged below five years, in Kenya,” Iranian Journal of Public Health, vol. 42, no. 2, pp. 129–133, 2013. View at Google Scholar · View at Scopus
  46. J. Nankabirwa, D. Zurovac, J. N. Njogu et al., “Malaria misdiagnosis in Uganda—implications for policy change,” Malaria Journal, vol. 8, no. 1, article 66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. A. K. Mbonye, S. Lal, B. Cundill, K. S. Hansen, S. Clarke, and P. Magnussen, “Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda,” Malaria Journal, vol. 12, no. 1, article 131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. N. J. White and W. Pongtavornpinyo, “The de novo selection of drug-resistant malaria parasites,” Proceedings of the Royal Society B: Biological Sciences, vol. 270, no. 1514, pp. 545–554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Armstrong-Schellenberg, C. G. Victora, A. Mushi et al., “Inequities among the very poor: health care for children in rural southern Tanzania,” The Lancet, vol. 361, no. 9357, pp. 561–566, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Toovey and A. Jamieson, “Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 98, no. 5, pp. 261–267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Yeung, W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White, “Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices,” American Journal of Tropical Medicine and Hygiene, vol. 71, supplement 2, pp. 179–186, 2004. View at Google Scholar · View at Scopus
  52. G. M. L. Nayyar, J. G. Breman, P. N. Newton, and J. Herrington, “Poor-quality antimalarial drugs in Southeast Asia and sub-Saharan Africa,” The Lancet Infectious Diseases, vol. 12, no. 6, pp. 488–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Makanga, Z. Premji, C. Falade et al., “Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data,” American Journal of Tropical Medicine and Hygiene, vol. 74, no. 6, pp. 991–998, 2006. View at Google Scholar · View at Scopus
  54. A. M. Dondorp, S. Yeung, L. White et al., “Artemisinin resistance: current status and scenarios for containment,” Nature Reviews Microbiology, vol. 8, no. 4, pp. 272–280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. M. Dondorp, F. Nosten, P. Yi et al., “Artemisinin resistance in Plasmodium falciparum malaria,” The New England Journal of Medicine, vol. 361, no. 5, pp. 455–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. I. M. Hastings and W. M. Watkins, “Intensity of malaria transmission and the evolution of drug resistance,” Acta Tropica, vol. 94, no. 3, pp. 218–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. A. O. Talisuna, P. Langi, N. Bakyaita et al., “Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 3, pp. 310–317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Twagirumukiza, P. C. Kayumba, J. G. Kips et al., “Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants,” Malaria Journal, vol. 9, no. 1, article 206, 2010. View at Publisher · View at Google Scholar · View at Scopus